- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT06112418
Ein randomisierter Vergleich der personalisierten Versorgung basierend auf der Stadieneinteilung von Herzerkrankungen mit der üblichen Versorgung zur Vorbeugung von Ereignissen (TRANSFORM)
Ein randomisierter Vergleich der personalisierten Versorgung basierend auf der Einstufung koronarer Herzkrankheiten mit der üblichen Versorgung zur Primärprävention kardiovaskulärer Ereignisse
TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests the hypothesis that a Cleerly Coronary Artery Disease (CAD) Staging System-based care strategy reduces CV events compared with risk factor-based care.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Cardiovascular disease (CVD) persists as the leading cause of morbidity and mortality worldwide at high societal cost. The current primary CVD prevention strategy relies upon risk stratification using population health markers such as age, sex, diabetes, hypertension, dyslipidemia and tobacco use, with preventive therapy intensified in higher risk strata. Since these risk factors are indirect surrogate markers of the underlying disease, atherosclerosis, this strategy leads to treatment of individuals with risk factors who do not have atherosclerosis and failure to treat those with significant atherosclerosis who lack risk factors. The current strategy also cannot determine which individuals are inadequately treated despite effective risk factor management (residual risk). With the current approach, the CV death rate is trending upward in the US despite evidence that screening asymptomatic patients reduces CV events and the widespread availability of effective preventive therapies.
This randomized, controlled, pragmatic trial is designed to address the unmet need for better strategies to identify asymptomatic individuals at increased risk for CV events due to atherosclerosis and to personalize their treatment based on CV risk estimates using coronary artery disease (CAD) visualization and quantification.
This study enrolls patients without known symptoms of ASCVD but who are at increased risk for ASCVD due to their age and having diabetes, prediabetes or metabolic syndrome and tests the hypothesis that a CAD Staging System-based care strategy reduces CV events compared with risk factor-based care. The Cleerly CAD Staging System incorporates imaging-based evaluation for coronary atherosclerosis, algorithm-supported pharmacotherapy and personalized education about their CAD.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Ryann Sardinia
- Telefonnummer: 7207398191
- E-Mail: ryann.sardinia@cleerlyhealth.com
Studieren Sie die Kontaktsicherung
- Name: Ashley Dunham, PhD
- Telefonnummer: 7207398191
- E-Mail: ashley.dunham@cleerlyhealth.com
Studienorte
-
-
Arizona
-
Chandler, Arizona, Vereinigte Staaten, 85224
- Rekrutierung
- Chandler Clinical Trials
-
Kontakt:
- Muhammad Salim, MD
-
Scottsdale, Arizona, Vereinigte Staaten, 85260
- Rekrutierung
- Scottsdale Clinical Trials
-
Kontakt:
- Todd Dreitzler, MD
-
Sun City, Arizona, Vereinigte Staaten, 85381
- Rekrutierung
- Sun City Research
-
Kontakt:
- Juan Rodriguez, MD
-
Tucson, Arizona, Vereinigte Staaten, 85704
- Rekrutierung
- Noble Clinical Research
-
Kontakt:
- Roxana Rodriguez, MD
-
-
California
-
Beverly Hills, California, Vereinigte Staaten, 90210
- Rekrutierung
- Cardiovascular Research Foundation of Southern California
-
Kontakt:
- Ronald P. Karlsberg, MD
-
Beverly Hills, California, Vereinigte Staaten, 90211
- Rekrutierung
- Amicis Research: Beverly Hills
-
Kontakt:
- Michael Levine, MD
-
Canoga Park, California, Vereinigte Staaten, 91303
- Rekrutierung
- Valiance Clinical Research - Canoga Park
-
Kontakt:
- Rami Shaarawy
-
Chula Vista, California, Vereinigte Staaten, 91911
- Rekrutierung
- Cardiovascular Institute of San Diego
-
Kontakt:
- Milind D. Parikh, MD
-
Granada Hills, California, Vereinigte Staaten, 91324
- Rekrutierung
- Amicis Research: Granada Hills
-
Kontakt:
- Pascal Dabel, MD
-
Huntington Park, California, Vereinigte Staaten, 90255
- Rekrutierung
- Valiance Clinical Research: Huntington Park
-
Kontakt:
- Philip Kim, MD
-
Indian Wells, California, Vereinigte Staaten, 92210
- Rekrutierung
- HALO Diagnostics
-
Kontakt:
- John F. Feller, MD
-
La Jolla, California, Vereinigte Staaten, 92037
- Rekrutierung
- Scripps Health
-
Kontakt:
- Elizabeth Epstein, MD
-
Lancaster, California, Vereinigte Staaten, 93534
- Rekrutierung
- Chemidox Clinical Trials
-
Kontakt:
- Pamela Dewar-DeSilva, MD
-
Loma Linda, California, Vereinigte Staaten, 92354
- Rekrutierung
- Loma Linda University Health
-
Kontakt:
- Purvi Parwani, MD
-
Long Beach, California, Vereinigte Staaten, 90805
- Rekrutierung
- Long Beach Research Institute
-
Kontakt:
- Ashley Duzik, MD
-
Monterey Park, California, Vereinigte Staaten, 91754
- Rekrutierung
- Ace Research Institute - Monterey Park
-
Kontakt:
- Yu-Hsiang Sam Lee, MD
-
Newhall, California, Vereinigte Staaten, 91321
- Rekrutierung
- Amicis Research: Newhall
-
Kontakt:
- Thuong Vo, MD
-
Northridge, California, Vereinigte Staaten, 91324
- Rekrutierung
- Ace Research Institute: Northridge
-
Kontakt:
- Richard Park, MD
-
Northridge, California, Vereinigte Staaten, 91324
- Rekrutierung
- Amicis Research: Northridge
-
Kontakt:
- Nana Barseghian, MD
-
Northridge, California, Vereinigte Staaten, 91325
- Rekrutierung
- Ace Research Institute: Northridge #2
-
Kontakt:
- William Y. Josephson, MD
-
Northridge, California, Vereinigte Staaten, 91325
- Aktiv, nicht rekrutierend
- Northridge Clinical Trials
-
Orange, California, Vereinigte Staaten, 92868
- Rekrutierung
- University of California- Irvine
-
Kontakt:
- Ailin Barseghian El-Farra, MD
-
Palo Alto, California, Vereinigte Staaten, 94304
- Rekrutierung
- Stanford Health Care
-
Kontakt:
- Sandra Tsai, MD
-
Palo Alto, California, Vereinigte Staaten, 94304
- Rekrutierung
- VA Palo Alto
-
Kontakt:
- Shriram Nallamshetty, MD
-
San Fernando, California, Vereinigte Staaten, 91306
- Rekrutierung
- Amicis Research: San Fernando
-
Kontakt:
- Farid Yasharpour, MD
-
Tarzana, California, Vereinigte Staaten, 91356
- Rekrutierung
- Valiance Clinical Research - Tarzana
-
Kontakt:
- Harpreet Singh, MD
-
Torrance, California, Vereinigte Staaten, 90502
- Rekrutierung
- Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center
-
Kontakt:
- Suvasini Lakshmanan, MD
-
Valencia, California, Vereinigte Staaten, 91355
- Rekrutierung
- Amicis Research: Valencia
-
Kontakt:
- Dennis Lewis, MD
-
Valley Village, California, Vereinigte Staaten, 91607
- Rekrutierung
- Concierge Clinical Trials
-
Kontakt:
- Neal R. Cutler, MD
-
-
Colorado
-
Aurora, Colorado, Vereinigte Staaten, 80045
- Rekrutierung
- University of Colorado
-
Kontakt:
- Steve Simon
-
Hauptermittler:
- Steve Simon, MD
-
Denver, Colorado, Vereinigte Staaten, 80218
- Rekrutierung
- St. Josephs (Intermountain Healthcare)
-
Kontakt:
- Christopher Angus, MD
-
-
Florida
-
Boca Raton, Florida, Vereinigte Staaten, 33434
- Rekrutierung
- Flourish Medical Research
-
Kontakt:
- Michael Hafran, MD
-
Cross City, Florida, Vereinigte Staaten, 32628
- Rekrutierung
- Apex Research
-
Kontakt:
- Tamir Salmani, MD
-
Hialeah, Florida, Vereinigte Staaten, 33012
- Rekrutierung
- Evolution Research Center
-
Kontakt:
- Riquel Gonzalez, MD
-
Jacksonville, Florida, Vereinigte Staaten, 32209
- Rekrutierung
- UF Health Jacksonville
-
Kontakt:
- Luis Ortega Paz, MD
-
Miami, Florida, Vereinigte Staaten, 33137
- Rekrutierung
- BioPhase Research
-
Kontakt:
- Julie Cadet-Plassman, MD
-
Miami, Florida, Vereinigte Staaten, 33135
- Rekrutierung
- Fiel Wellness Clinical Research LLC
-
Kontakt:
- Osvaldo Caroma, MD
-
Miami, Florida, Vereinigte Staaten, 33155
- Rekrutierung
- United Clinical Research
-
Kontakt:
- Teresa B. Alfonso, MD
-
Kontakt:
- Alfonso
-
Miami, Florida, Vereinigte Staaten, 33173
- Rekrutierung
- Atlantis Clinical Research, LLC
-
Kontakt:
- Leyvi Alvarado Miranda, MD
-
Miami, Florida, Vereinigte Staaten, 33183
- Rekrutierung
- Farma Medical Inc.
-
Kontakt:
- Ingrid Fernandez-Milian, MD
-
Miami, Florida, Vereinigte Staaten, 33173
- Rekrutierung
- Baptist Health Miami Cardiac and Vascular Institute
-
Kontakt:
- Jonathan Fialkow, MD
-
Miami, Florida, Vereinigte Staaten, 33186
- Rekrutierung
- New Access Research and Medical Center
-
Kontakt:
- Sander Fernandez, MD
-
Miami Beach, Florida, Vereinigte Staaten, 33140
- Rekrutierung
- Quantum Clinical Trials
-
Kontakt:
- Christopher A. Fayeghi, MD
-
Pensacola, Florida, Vereinigte Staaten, 32504
- Rekrutierung
- Ascension Sacred Heart
-
Kontakt:
- Rohit Amin, MD
-
Pompano Beach, Florida, Vereinigte Staaten, 33060
- Rekrutierung
- Clinical Research Center of Florida
-
Kontakt:
- Howard S. Koch, MD
-
Tampa, Florida, Vereinigte Staaten, 33620
- Rekrutierung
- University of South Florida
-
Kontakt:
- Shone Almeida, MD
-
-
Georgia
-
Augusta, Georgia, Vereinigte Staaten, 30907
- Rekrutierung
- Aiyan Diabetes Center
-
Kontakt:
- Anthony D. Turner, MD
-
Dunwoody, Georgia, Vereinigte Staaten, 30338
- Rekrutierung
- Emory University
-
Kontakt:
- Ambar Kulshreshtha, MD
-
Fayetteville, Georgia, Vereinigte Staaten, 30214
- Rekrutierung
- Privia Medical Group Georgia LLC -Fayetteville (Javara)
-
Kontakt:
- Charlotte Grayson Mathis, MD
-
Lithia Springs, Georgia, Vereinigte Staaten, 30122
- Rekrutierung
- Randomize Now- Atlanta West
-
Kontakt:
- Millard Collier Jr., MD
-
Macon, Georgia, Vereinigte Staaten, 31210
- Rekrutierung
- Randomize Now-Burton Medical
-
Kontakt:
- Frederick Burton, MD
-
Norcross, Georgia, Vereinigte Staaten, 30092
- Rekrutierung
- Evergreen Clinical Trials
-
Kontakt:
- Dmitriy Pelishev, MD
-
Powder Springs, Georgia, Vereinigte Staaten, 30127
- Rekrutierung
- Peachtree Clinical Solutions - Noir Research Collective
-
Kontakt:
- Karan Raghavan, MD
-
Riverdale, Georgia, Vereinigte Staaten, 30296
- Rekrutierung
- Randomize Now, LLC - Noir Research Collective
-
Kontakt:
- Claire K. Willie, MD
-
Savannah, Georgia, Vereinigte Staaten, 31406
- Rekrutierung
- Privia Medical Group Georgia, LLC (Javara Inc.)
-
Kontakt:
- Thomas G. Moriarity, MD
-
Thomasville, Georgia, Vereinigte Staaten, 31792
- Rekrutierung
- Privia Medical Group Georgia - Thomasville (Javara)
-
Kontakt:
- William L. Cooper, MD
-
-
Idaho
-
Meridian, Idaho, Vereinigte Staaten, 83642
- Rekrutierung
- Care Institute- High Desert
-
Kontakt:
- David A. Hinchman, MD
-
-
Illinois
-
Chicago, Illinois, Vereinigte Staaten, 60611
- Rekrutierung
- Northwestern University
-
Kontakt:
- Paul C. Cremer, MD
-
Glenview, Illinois, Vereinigte Staaten, 60026
- Rekrutierung
- Northshore University Health System
-
Kontakt:
- Amit K. Pursnani, MD
-
-
Indiana
-
Indianapolis, Indiana, Vereinigte Staaten, 46237
- Rekrutierung
- Franciscan Physician Network- Indiana Heart Physicians
-
Kontakt:
- Ryan P Daly, MD
-
Indianapolis, Indiana, Vereinigte Staaten, 46202
- Rekrutierung
- Indiana Medical Research Institute
-
Kontakt:
- Arshad P. Malik
-
-
Iowa
-
West Des Moines, Iowa, Vereinigte Staaten, 50266
- Rekrutierung
- MercyOne Iowa Heart Center
-
Kontakt:
- Enrico L. Martin, MD
-
-
Kentucky
-
Edgewood, Kentucky, Vereinigte Staaten, 41017
- Rekrutierung
- St Elizabeth Health Care - CRI
-
Kontakt:
- Erica Pivato, MD
-
Louisville, Kentucky, Vereinigte Staaten, 40202
- Rekrutierung
- UofL Health
-
Kontakt:
- Shahab Ghafghazi, MD
-
-
Louisiana
-
New Orleans, Louisiana, Vereinigte Staaten, 70127
- Rekrutierung
- Ascension DePaul Services Research Center
-
Kontakt:
- Kristen Thomas, MD
-
-
Maryland
-
Bowie, Maryland, Vereinigte Staaten, 20715
- Rekrutierung
- Flourish Bowie dba Flourish Research
-
Kontakt:
- Sara Collins, MD
-
Columbia, Maryland, Vereinigte Staaten, 21045
- Rekrutierung
- KUR Research at CMP
-
Kontakt:
- William Saway, MD
-
-
Massachusetts
-
Boston, Massachusetts, Vereinigte Staaten, 02115
- Rekrutierung
- Brigham and Women's Hospital
-
Kontakt:
- Ron Blankstein, MD
-
Boston, Massachusetts, Vereinigte Staaten, 02114
- Rekrutierung
- Massachusetts General Hospital
-
Kontakt:
- Pradeep Natarajan, MD
-
-
Michigan
-
Detroit, Michigan, Vereinigte Staaten, 48202
- Rekrutierung
- Henry Ford Hospital
-
Kontakt:
- Cori E Russell, MD
-
Ypsilanti, Michigan, Vereinigte Staaten, 48917
- Rekrutierung
- Trinity Health Michigan Heart
-
Kontakt:
- Ahmad Mizyed, MD
-
-
Minnesota
-
Minneapolis, Minnesota, Vereinigte Staaten, 55407
- Rekrutierung
- Minneapolis Heart Institute Foundation
-
Kontakt:
- Michael D. Miedema, MD
-
-
Missouri
-
St Louis, Missouri, Vereinigte Staaten, 63110
- Rekrutierung
- Washington University School of Medicine
-
Kontakt:
- Farhan M. Katchi, MD
-
St Louis, Missouri, Vereinigte Staaten, 63136
- Rekrutierung
- Saint Louis Heart and Vascular
-
Kontakt:
- Gil Vardi, MD
-
-
Montana
-
Kalispell, Montana, Vereinigte Staaten, 59901
- Rekrutierung
- Boeson Research Kalispell
-
Kontakt:
- Justin Buls, MD
-
Missoula, Montana, Vereinigte Staaten, 59804
- Rekrutierung
- Boeson Research Fort Missoula
-
Kontakt:
- Audrey Remmers, MD
-
-
Nebraska
-
Lincoln, Nebraska, Vereinigte Staaten, 68506
- Rekrutierung
- Bryan Heart
-
Kontakt:
- Chad E. Travers, MD
-
-
Nevada
-
Las Vegas, Nevada, Vereinigte Staaten, 89128
- Rekrutierung
- Vector Clinical Trials
-
Kontakt:
- Bharat R. Mocherla, MD
-
Las Vegas, Nevada, Vereinigte Staaten, 89102
- Rekrutierung
- Southwest Medical Associates- Optum Nevada
-
Kontakt:
- Tatiana O. Tsvetkova, MD
-
-
New Jersey
-
Flemington, New Jersey, Vereinigte Staaten, 08822
- Rekrutierung
- Advanced Heart and Vascular Institute of Hunterdon
-
Kontakt:
- Andrey Espinoza, MD
-
Marlton, New Jersey, Vereinigte Staaten, 08053
- Rekrutierung
- Virtua Health, Inc.
-
Kontakt:
- Mark T. Finch, MD
-
New Brunswick, New Jersey, Vereinigte Staaten, 08901
- Rekrutierung
- Rutgers State University
-
Kontakt:
- Sabahat Bokhari, MD
-
Paramus, New Jersey, Vereinigte Staaten, 07652
- Rekrutierung
- The Valley Hospital
-
Kontakt:
- Himanshu Gupta, MD
-
Teaneck, New Jersey, Vereinigte Staaten, 07666
- Rekrutierung
- Holy Name Medical Center
-
Kontakt:
- Jaffar Raza, MD
-
-
New York
-
Brooklyn, New York, Vereinigte Staaten, 11221
- Rekrutierung
- Clindove Research
-
Kontakt:
- Nelly Cohen, MD
-
Brooklyn, New York, Vereinigte Staaten, 11226
- Rekrutierung
- Swift Clinical Research
-
Kontakt:
- Manoj Dalmia, MD
-
Jackson Heights, New York, Vereinigte Staaten, 11372
- Rekrutierung
- Rasaj Research
-
Kontakt:
- Ammara Mushtaq, MD
-
Lake Success, New York, Vereinigte Staaten, 11042
- Rekrutierung
- Optum- Long Island NY
-
Kontakt:
- Steven Goldberg, MD
-
Mount Kisco, New York, Vereinigte Staaten, 10549
- Rekrutierung
- Northwell Health Northern Westchester Hospital
-
Kontakt:
- Margaret Andersen, MD
-
New York, New York, Vereinigte Staaten, 10019
- Rekrutierung
- Mount Sinai West
-
Kontakt:
- Waqas A Malick, MD
-
New York, New York, Vereinigte Staaten, 10029
- Rekrutierung
- Mount Sinai
-
Kontakt:
- Solomon Bienstock, MD
-
-
North Carolina
-
Chapel Hill, North Carolina, Vereinigte Staaten, 27599
- Rekrutierung
- University of North Carolina at Chapel Hill
-
Kontakt:
- Matthew Cavender, MD
-
Durham, North Carolina, Vereinigte Staaten, 27701
- Rekrutierung
- Duke University Hospital
-
Kontakt:
- William Yancy, MD
-
Durham, North Carolina, Vereinigte Staaten, 27705
- Rekrutierung
- Durham Veterans Affairs Medical Center (Durham VAMC)
-
Kontakt:
- Hayden Bosworth, MD
-
Fayetteville, North Carolina, Vereinigte Staaten, 28304
- Rekrutierung
- Cape Fear Valley Health System (Javara Inc.)
-
Kontakt:
- Nafisa Saleem, MD
-
Morehead City, North Carolina, Vereinigte Staaten, 28557
- Aktiv, nicht rekrutierend
- West Clinical Research
-
Winston-Salem, North Carolina, Vereinigte Staaten, 27157
- Rekrutierung
- Wake Forest University Health Sciences
-
Kontakt:
- Michael Shapiro, MD
-
-
North Dakota
-
Fargo, North Dakota, Vereinigte Staaten, 58102
- Rekrutierung
- Sanford Health
-
Kontakt:
- David J. Clardy, MD
-
-
Ohio
-
Akron, Ohio, Vereinigte Staaten, 44304
- Rekrutierung
- Summa Health
-
Kontakt:
- Wissam Alajaji, MD
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Vereinigte Staaten, 73109
- Rekrutierung
- Medical Research International, LLC
-
Kontakt:
- Joseph Grillo, MD
-
Oklahoma City, Oklahoma, Vereinigte Staaten, 73007
- Rekrutierung
- Hightower Clinical
-
Kontakt:
- Faisal Latif, MD
-
Tulsa, Oklahoma, Vereinigte Staaten, 74104
- Rekrutierung
- Ascension St. John - Jane Phillips Medical Center
-
Kontakt:
- Michael Megaly, MD
-
-
Pennsylvania
-
Camp Hill, Pennsylvania, Vereinigte Staaten, 17011
- Rekrutierung
- Capital Area Research
-
Kontakt:
- Venkatesh Nadar, MD
-
-
South Carolina
-
Charleston, South Carolina, Vereinigte Staaten, 29425
- Rekrutierung
- Medical University of South Carolina
-
Kontakt:
- Marc-Andre Cornier, MD
-
-
Tennessee
-
Cleveland, Tennessee, Vereinigte Staaten, 37312
- Rekrutierung
- Community DPC
-
Kontakt:
- Carlton Volberg, MD
-
Knoxville, Tennessee, Vereinigte Staaten, 37920
- Rekrutierung
- University of Tennessee Medical Center
-
Kontakt:
- Kashif A. Shaikh, MD
-
Nashville, Tennessee, Vereinigte Staaten, 37202
- Rekrutierung
- TriStar Centennial Medical Center (HCA Health Care)
-
Kontakt:
- David Huneycutt, MD
-
-
Texas
-
Abilene, Texas, Vereinigte Staaten, 79601
- Rekrutierung
- Hendrick Health
-
Kontakt:
- Ren Zhang, MD
-
Beaumont, Texas, Vereinigte Staaten, 77702
- Rekrutierung
- Gadolin Research
-
Kontakt:
- John T Fowler, MD
-
Greenville, Texas, Vereinigte Staaten, 75402
- Rekrutierung
- CardioVoyage, LLC
-
Kontakt:
- Marc Demyun, MD
-
Houston, Texas, Vereinigte Staaten, 77025
- Rekrutierung
- Kelsey Research Foundation
-
Kontakt:
- Rohan R Wagle, MD
-
Houston, Texas, Vereinigte Staaten, 77004
- Rekrutierung
- Helium Research Group
-
Kontakt:
- Ijeoma A. Ekeruo
-
Houston, Texas, Vereinigte Staaten, 77070
- Rekrutierung
- Gulf Coast Clinical Research, LLC
-
Kontakt:
- Anjani Pandya, MD
-
Houston, Texas, Vereinigte Staaten, 77030
- Rekrutierung
- The Methodist Hospital, DeBakey Cardiology Associates
-
Kontakt:
- Sadeer Al-Kindi, MD
-
Laredo, Texas, Vereinigte Staaten, 78041
- Rekrutierung
- Aeres Clinical Research
-
Kontakt:
- Amando Garza, MD
-
Lewisville, Texas, Vereinigte Staaten, 75057
- Rekrutierung
- DC Clinical Research
-
Kontakt:
- Moiz M. Shafiq, MD
-
McKinney, Texas, Vereinigte Staaten, 75069
- Rekrutierung
- North Dallas Research Associates - Kerlo Network
-
Kontakt:
- Muhammad Akram Khan, MD
-
Mesquite, Texas, Vereinigte Staaten, 75149
- Rekrutierung
- SMS Clinical Research
-
Kontakt:
- Salma Saiger, MD
-
San Marcos, Texas, Vereinigte Staaten, 78666
- Rekrutierung
- Privia Medical Group Gulf Coast, PLLC ( Javara Inc.)
-
Kontakt:
- Alan Lee, MD
-
Stephenville, Texas, Vereinigte Staaten, 76401
- Rekrutierung
- Privia Medical Group- North Texas
-
Kontakt:
- Benjamin Marcum, MD
-
-
Utah
-
West Valley City, Utah, Vereinigte Staaten, 84120
- Noch keine Rekrutierung
- Kalo Clinical Research
-
Kontakt:
- William J. Walsh, MD
-
-
Virginia
-
Richmond, Virginia, Vereinigte Staaten, 23225
- Rekrutierung
- Chippenham Johnston Willis Medical Center
-
Kontakt:
- Michael Arcarese, MD
-
-
Washington
-
Everett, Washington, Vereinigte Staaten, 98201
- Rekrutierung
- Providence Regional Medical Center Everett
-
Kontakt:
- Xiaojing Jennie Shen, MD
-
Seattle, Washington, Vereinigte Staaten, 98195
- Rekrutierung
- University of Washington
-
Kontakt:
- Kelley Branch, MD
-
-
West Virginia
-
Charleston, West Virginia, Vereinigte Staaten, 25304
- Rekrutierung
- Charleston Area Medical Center
-
Kontakt:
- Sarah Rinehart, MD
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
-
Provided electronic or written informed consent
-
Men > 55, women > 65 years of age
-
Type 2 diabetes mellitus requiring pharmacologic therapy, prediabetes (most recent HbA1c 5.7 to 6.4% and/or fasting glucose 100-125 mg/dL [5.6-6.9 mmol/L]) and/or metabolic syndrome. Metabolic syndrome is defined as > 3 of the following criteria (International Diabetes Federation 2006):
- Body mass index ≥ 27 kg/m2 or abnormal waist circumference defined as ≥ 80 cm (31.5 inches) for women, ≥ 94 cm (37 inches) for men; for South and East Asian men (e.g., Asian Indian, Chinese, Japanese) ≥ 90 cm (35.4 inches)
- Fasting triglycerides ≥ 150 mg/dL (1.7 mmol/L) or treated hypertriglyceridemia
- HDL-cholesterol (HDL-C) < 40 mg/dL (1.03 mmol/L) in men, <50 mg/dL (1.29 mmol/L) in women or treatment for this lipid abnormality
- Systolic blood pressure (BP) ≥ 130 and/or diastolic BP≥ 85 mm Hg and/or treated hypertension
- Fasting blood glucose ≥ 100 mg/dL (5.6 mmol/L) or HbA1c ≥ 5.7%
-
Have a device (e.g., smartphone, tablet, computer) for communication with the central cardiologist-led team managing drug treatment for the personalized care group
Exclusion Criteria:
-
History of symptomatic CVD defined as prior MI, exertional or unstable angina, ischemic stroke, claudication, arterial revascularization for atherosclerosis or other CVD being actively managed by a cardiologist, e.g. atrial fibrillation, heart failure
-
Planned arterial revascularization
-
Inability to complete screening CCTA or any condition that would increase the risk associated with CCTA or increase likelihood of uninterpretable scan including:
- eGFR < 60 mL/min/1.73 m2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) or Modification of Diet in Renal Disease (MDRD) equation (www.kidney.org/professionals/kdoqi/gfr_calculator)
- Allergy to iodinated contrast or history of contrast-induced nephropathy (including adverse reaction to contrast at screening CCTA) or screening laboratory values consistent with untreated hyperthyroidism. Participants with elevated thyroid-stimulating hormone (TSH) may be enrolled but should be referred to their physician for evaluation for treatment.
- Thyroid cancer in the previous five (5) years or planned radioactive iodine treatment
- Weight > 300 lbs. (136 kg) or above manufacturer-recommended limit for scanner and table at the site
- Inability to hold breath for > 10 seconds
- Active arrhythmia (atrial fibrillation, atrial flutter, frequent premature atrial, or ventricular contractions) with poorly controlled rate (i.e., > 80 beats per minute at screening or prior to CCTA)
- Contraindication to dosing with beta blocker or nitroglycerin on day of screening CCTA
- Any other factor that, in the opinion of the investigator, would increase participant risk or increase the chance of an uninterpretable CCTA
-
Unsuitable as a trial participant in the opinion of the investigator for reasons including significant left main stenosis (e.g. ≥ 70%; site will be notified by Cleerly), other health condition with life expectancy < 3 years or being at risk of poor compliance with study procedures (e.g., active substance abuse or untreated mental illness that, in the opinion of the investigator, is likely to adversely affect adherence or retention)
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Kein Eingriff: Risk Factor-Based Care
The risk factor-based care group will be managed by their usual care providers, with an initial pre-randomization assessment of current treatment by a centralized cardiology team to optimize care relative to primary prevention guidelines. During the trial, the centralized cardiology team will monitor the provision of medications prescribed and lab values relative to guidelines, and provide feedback and education to site investigators to support optimization. CCTA results will be centrally archived and will remain blinded to the usual care provider until the end of the study. |
|
|
Experimental: Cleerly Stage-Based Care
The Cleerly Stage-Based Care group will receive personalized care centrally managed by a remote cardiologist-led team. They will also receive an initial pre-randomization assessment of current treatment by a centralized cardiology team to optimize care relative to primary prevention guidelines. Cleerly CAD Staging System results will be discussed with participants and serve as the basis for standardized algorithm-supported pharmacotherapy & education, which will be intensified if plaque burden has progressed at 24 months. |
The Cleerly CAD Staging System is software that utilizes a proprietary algorithm to identify CAD, stage the severity of CAD when present, and generate a prognostic risk score to inform treatment decisions that support CV disease prevention. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
The primary objective is to compare Cleerly stage-based care with risk factor-based care on the risk of CV events.
Zeitfenster: Through study completion- an average of 3.5 years
|
The primary endpoint is total (first and subsequent) events for the composite endpoint of CV death, myocardial infarction (MI), ischemic stroke, acute limb ischemia, clinically driven arterial revascularization, and hospitalization or urgent visit for heart failure. |
Through study completion- an average of 3.5 years
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Zeitfenster: Through study completion- an average of 3.5 years
|
The secondary endpoints are time from randomization to first occurence of an event in the primary efficacy endpoint. |
Through study completion- an average of 3.5 years
|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Zeitfenster: Through study completion- an average of 3.5 years
|
The secondary endpoints are total occurences after randomization of the primary efficacy endpoing, kidney failure, sustained estimated glomerular filtration rate (eGFR) decrease >40% from baseline, and death from renal causes. |
Through study completion- an average of 3.5 years
|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Zeitfenster: Through study completion- an average of 3.5 years
|
The secondary endpoints are first and total occurrences after randomization of coronary death, MI, and urgent coronary revascularization. |
Through study completion- an average of 3.5 years
|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Zeitfenster: Through study completion- an average of 3.5 years
|
The secondary endpoints are time from randomization to first occurrence of MI or ischemic stroke. |
Through study completion- an average of 3.5 years
|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Zeitfenster: Through study completion- an average of 3.5 years
|
The secondary endpoints are time from randomization to all-cause death. |
Through study completion- an average of 3.5 years
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
The safety objective is to assess harm with the 2 prevention strategies
Zeitfenster: Through study completion- an average of 3.5 years
|
The safety endpoints are Adverse events (AE) leading to discontinuation of study-recommended medication (DAE), serious AE (SAE), adverse device effect (ADE). |
Through study completion- an average of 3.5 years
|
|
The safety objective is to assess harm with the 2 prevention strategies
Zeitfenster: Through study completion- an average of 3.5 years
|
The safety endpoints are 20-item Short Form survey (SF-20). |
Through study completion- an average of 3.5 years
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Studienstuhl: Deepak Bhatt, MD, MPH, Mt. Sinai Heart
- Studienstuhl: David J. Maron, MD, FASPC, Stanford University
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Clerc OF, Fuchs TA, Stehli J, Benz DC, Grani C, Messerli M, Giannopoulos AA, Buechel RR, Luscher TF, Pazhenkottil AP, Kaufmann PA, Gaemperli O. Non-invasive screening for coronary artery disease in asymptomatic diabetic patients: a systematic review and meta-analysis of randomised controlled trials. Eur Heart J Cardiovasc Imaging. 2018 Aug 1;19(8):838-846. doi: 10.1093/ehjci/jey014.
- Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Ferguson JF, Generoso G, Ho JE, Kalani R, Khan SS, Kissela BM, Knutson KL, Levine DA, Lewis TT, Liu J, Loop MS, Ma J, Mussolino ME, Navaneethan SD, Perak AM, Poudel R, Rezk-Hanna M, Roth GA, Schroeder EB, Shah SH, Thacker EL, VanWagner LB, Virani SS, Voecks JH, Wang NY, Yaffe K, Martin SS. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
Nützliche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 202302CPC
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .